These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24210818)

  • 21. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells.
    Zhu D; Shen Z; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y
    Toxicol Lett; 2016 Dec; 264():79-86. PubMed ID: 27856279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.
    Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ
    Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
    Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
    Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
    Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S
    Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
    Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK
    Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity, cholesterol metabolism, and breast cancer pathogenesis.
    McDonnell DP; Park S; Goulet MT; Jasper J; Wardell SE; Chang CY; Norris JD; Guyton JR; Nelson ER
    Cancer Res; 2014 Sep; 74(18):4976-82. PubMed ID: 25060521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 27-Hydroxycholesterol-induced EndMT acts
    Jiao K; Zhen J; Wu M; Teng M; Yang K; Zhou Q; Hu C; Zhou M; Li Y; Li Z
    Cancer Biol Med; 2020 Feb; 17(1):88-100. PubMed ID: 32296578
    [No Abstract]   [Full Text] [Related]  

  • 28. Re-adopting classical nuclear receptors by cholesterol metabolites.
    Umetani M
    J Steroid Biochem Mol Biol; 2016 Mar; 157():20-6. PubMed ID: 26563834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of STAT-3 signalling by RECK downregulation
    Shen Z; Jiao K; Teng M; Li Z
    Free Radic Res; 2020 Mar; 54(2-3):126-136. PubMed ID: 31933392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol.
    Hiramitsu S; Ishikawa T; Lee WR; Khan T; Crumbley C; Khwaja N; Zamanian F; Asghari A; Sen M; Zhang Y; Hawse JR; Minna JD; Umetani M
    Front Endocrinol (Lausanne); 2018; 9():470. PubMed ID: 30190703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
    Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
    Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.
    McDonnell DP; Chang CY; Nelson ER
    Climacteric; 2014 Dec; 17 Suppl 2(0 2):60-5. PubMed ID: 25320023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
    Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
    Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling.
    Houben T; Bitorina AV; Oligschlaeger Y; Jeurissen ML; Rensen S; Köhler SE; Westerterp M; Lütjohann D; Theys J; Romano A; Plat J; Shiri-Sverdlov R
    J Pathol; 2020 Aug; 251(4):429-439. PubMed ID: 32472585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of 27-hydroxycholesterol on the progression of non-small cell lung cancer via the estrogen receptor.
    Takada I; Miyazaki T; Goto Y; Kanzawa H; Matsubara T; Namikawa-Kanai H; Shigefuku S; Ono S; Nakajima E; Morishita Y; Honda A; Furukawa K; Ikeda N
    Am J Cancer Res; 2022; 12(9):4241-4253. PubMed ID: 36225627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
    Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
    Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
    Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
    Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
    Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host CYP27A1 expression is essential for ovarian cancer progression.
    He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER
    Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch activation stimulates migration of breast cancer cells and promotes tumor growth.
    Bolós V; Mira E; Martínez-Poveda B; Luxán G; Cañamero M; Martínez-A C; Mañes S; de la Pompa JL
    Breast Cancer Res; 2013; 15(4):R54. PubMed ID: 23826634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.